Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant

CONCLUSIONS: A decrease in CMV-specific T-cell responses during the first month after transplant may predict CS-CMVi and is associated with all-cause mortality in recipients of alloHCT.PMID:37636519 | PMC:PMC10460252 | DOI:10.1093/ofid/ofad386

Source: Cancer Control - August 28, 2023 Category: Cancer & Oncology Authors: Ella J Ariza-Heredia Drew J Winston Scott D Rowley Kathleen Mullane Pranatharthi Chandrasekar Parameswaran Hari Robin K Avery Karl S Peggs Deepali Kumar Rajneesh Nath Per Ljungman Sherif B Mossad Lynn El Haddad Dimpy P Shah Ying Jiang Fareed Khawaja Sanje Source Type: research